Unknown

Dataset Information

0

A Mechanistic Model for Predicting Cell Surface Presentation of Competing Peptides by MHC Class I Molecules.


ABSTRACT: Major histocompatibility complex-I (MHC-I) molecules play a central role in the immune response to viruses and cancers. They present peptides on the surface of affected cells, for recognition by cytotoxic T cells. Determining which peptides are presented, and in what proportion, has profound implications for developing effective, medical treatments. However, our ability to predict peptide presentation levels is currently limited. Existing prediction algorithms focus primarily on the binding affinity of peptides to MHC-I, and do not predict the relative abundance of individual peptides on the surface of antigen-presenting cells in situ which is a critical parameter for determining the strength and specificity of the ensuing immune response. Here, we develop and experimentally verify a mechanistic model for predicting cell-surface presentation of competing peptides. Our approach explicitly models key steps in the processing of intracellular peptides, incorporating both peptide binding affinity and intracellular peptide abundance. We use the resulting model to predict how the peptide repertoire is modified by interferon-?, an immune modulator well known to enhance expression of antigen processing and presentation proteins.

SUBMITTER: Boulanger DSM 

PROVIDER: S-EPMC6041393 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Mechanistic Model for Predicting Cell Surface Presentation of Competing Peptides by MHC Class I Molecules.

Boulanger Denise S M DSM   Eccleston Ruth C RC   Phillips Andrew A   Coveney Peter V PV   Elliott Tim T   Dalchau Neil N  

Frontiers in immunology 20180705


Major histocompatibility complex-I (MHC-I) molecules play a central role in the immune response to viruses and cancers. They present peptides on the surface of affected cells, for recognition by cytotoxic T cells. Determining which peptides are presented, and in what proportion, has profound implications for developing effective, medical treatments. However, our ability to predict peptide presentation levels is currently limited. Existing prediction algorithms focus primarily on the binding affi  ...[more]

Similar Datasets

| S-EPMC8931367 | biostudies-literature
| S-EPMC2212666 | biostudies-literature
2005-04-01 | GSE2435 | GEO
2010-12-01 | E-MEXP-3007 | biostudies-arrayexpress
| S-EPMC1142372 | biostudies-literature
| S-EPMC5101130 | biostudies-literature
| S-EPMC4321303 | biostudies-literature
| S-EPMC5159193 | biostudies-literature
| S-EPMC3221928 | biostudies-literature
| S-EPMC5766668 | biostudies-literature